Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)

Lip, Gregory; Collet, Jean; de Caterina, Raffaele; Fauchier, Laurent; Lane, Deirdre; Larsen, Torben; Marin, Francisco; Morais, Joao; Narasimhan, Calambur; Olshansky, Brian; Pierard, Luc; Potpara, Tatjana; Sarrafzadegan, Nizal; Sliwa, Karen; Varela, Gonzalo; Vilahur, Gemma; Weiss, Thomas; Boriani, Giuseppe; Rocca, Bianca; GÖRENEK, BÜLENT; Savelieva, Irina; Sticherling, Christian; Kudaiberdieva, Gulmira; Chao, Tze-Fan; Violi, Francesco; Nair, Mohan; Zimerman, Leandro; Piccini, Jonathan; Storey, Robert; Halvorsen, Sigrun; Gorog, Diana; Rubboli, Andrea; Chin, Ashley; Scott-Millar, Robert

doi:10.1093/europace/eux240

Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)

Atıf İçin Kopyala

Lip G. Y. H. , Collet J. P. , de Caterina R., Fauchier L., Lane D. A. , Larsen T. B. , ...Daha Fazla

EUROPACE, cilt.19, sa.11, ss.1757-1777, 2017 (SCI İndekslerine Giren Dergi)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 19 Konu: 11
Basım Tarihi: 2017
Doi Numarası: 10.1093/europace/eux240
Dergi Adı: EUROPACE
Sayfa Sayıları: ss.1757-1777

Özet

Atrial fibrillation (AF) is a major worldwide public health problem, and AF in association with valvular heart disease (VHD) is also common. However, management strategies for this group of patients have been less informed by randomized trials, which have largely focused on 'non-valvular AF' patients.